Frontiers | EGFR/FOXO3A/LXR-α Axis Promotes Prostate Cancer Proliferation and Metastasis and Dual-Targeting LXR-α/EGFR Shows Synthetic Lethality | Oncology
Approved LXR agonists exert unspecific effects on pancreatic β-cell function | SpringerLink
LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer - ScienceDirect
Approved LXR agonists exert unspecific effects on pancreatic β-cell function | SpringerLink
Liver X Receptor Agonists as Potential Therapeutic Agents for Dyslipidemia and Atherosclerosis | Arteriosclerosis, Thrombosis, and Vascular Biology
LXR agonism promotes macroscopic change in the tumor microenvironment
Approved LXR agonists exert unspecific effects on pancreatic β-cell function | SpringerLink
Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR - ScienceDirect
An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers - ScienceDirect
Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice* - Journal of Biological Chemistry
Liver X receptors as potential targets for cancer therapeutics (Review)
Frontiers | Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer | Immunology
LXR Agonist-treated EOCs Decrease Atherosclerosis | Stem Cells Portal
Liver X receptors link lipid metabolism and inflammation - Schulman - 2017 - FEBS Letters - Wiley Online Library
LXR-inverse agonism stimulates immune-mediated tumor destruction by enhancing CD8 T-cell activity in triple negative breast cancer | Scientific Reports
Activation of LXRβ inhibits tumor respiration and is synthetically lethal with Bcl‐xL inhibition | EMBO Molecular Medicine
Molecules | Free Full-Text | Ligands of Therapeutic Utility for the Liver X Receptors | HTML
Targeting liver X receptors in cancer therapeutics | Nature Reviews Cancer
Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression - eBioMedicine
Synthetic LXR agonists. | Download Scientific Diagram
